Inotiv Inc (NOTV)
1.76
+0.04
(+2.33%)
USD |
NASDAQ |
Jun 14, 16:00
1.74
-0.02
(-1.14%)
After-Hours: 20:00
Inotiv Cash from Financing (Quarterly): -1.173M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -1.173M |
December 31, 2023 | -2.921M |
September 30, 2023 | -0.31M |
June 30, 2023 | -1.042M |
March 31, 2023 | -1.16M |
December 31, 2022 | 18.38M |
September 30, 2022 | 13.99M |
June 30, 2022 | -1.369M |
March 31, 2022 | 71.06M |
December 31, 2021 | 119.47M |
September 30, 2021 | 134.57M |
June 30, 2021 | 65.58M |
March 31, 2021 | -0.892M |
December 31, 2020 | -0.429M |
September 30, 2020 | -0.209M |
June 30, 2020 | 3.253M |
March 31, 2020 | 2.048M |
December 31, 2019 | 4.549M |
September 30, 2019 | 2.238M |
June 30, 2019 | 2.913M |
March 31, 2019 | 1.327M |
December 31, 2018 | -0.273M |
September 30, 2018 | 5.188M |
June 30, 2018 | -0.089M |
March 31, 2018 | -0.087M |
Date | Value |
---|---|
December 31, 2017 | -0.086M |
September 30, 2017 | -0.337M |
June 30, 2017 | -0.136M |
March 31, 2017 | 0.632M |
December 31, 2016 | -1.008M |
September 30, 2016 | -0.477M |
June 30, 2016 | 0.10M |
March 31, 2016 | 0.042M |
December 31, 2015 | 0.479M |
September 30, 2015 | -0.208M |
June 30, 2015 | -0.259M |
March 31, 2015 | -0.753M |
December 31, 2014 | 0.007M |
September 30, 2014 | -0.139M |
June 30, 2014 | 0.372M |
March 31, 2014 | -0.324M |
December 31, 2013 | -1.422M |
September 30, 2013 | 0.869M |
June 30, 2013 | -0.75M |
March 31, 2013 | -0.378M |
December 31, 2012 | -0.763M |
September 30, 2012 | -0.025M |
June 30, 2012 | -0.204M |
March 31, 2012 | -0.503M |
December 31, 2011 | -0.432M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.921M
Minimum
Dec 2023
134.57M
Maximum
Sep 2021
21.43M
Average
2.143M
Median
Cash from Financing (Quarterly) Benchmarks
Biolase Inc | 5.647M |
Akoya Biosciences Inc | -0.444M |
Durect Corp | -1.495M |
Macrogenics Inc | 0.248M |
Candel Therapeutics Inc | -1.255M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 16.92M |
Cash from Investing (Quarterly) | -4.587M |
Free Cash Flow | 9.573M |
Free Cash Flow Per Share (Quarterly) | 0.3831 |
Free Cash Flow to Equity (Quarterly) | 8.605M |
Free Cash Flow to Firm (Quarterly) | 19.69M |
Free Cash Flow Yield | 21.10% |